Risk factors for gout in Togolese patients
- PMID: 11143911
Risk factors for gout in Togolese patients
Abstract
Objective: To determine the risk factors for gout in Togolese patients.
Methods: The medical records of patients admitted to the Lomé Teaching Hospital (Togo) rheumatology department over a ten-year period were reviewed retrospectively.
Results: Of the 8351 study patients, 160 (1.9%) fulfilled American Rheumatism Association criteria for gout; 159 were male. Mean age at disease onset was 44 years, and mean disease duration was six years. Tophi were recorded in 35 cases and a history of renal colic in one. Only five patients (3.1%) had no identifiable risk factors. The main risk factors in the remaining patients were alcohol abuse (133/160, 83.12%), overweight/obesity (64/160, 40%), and hypertension (42/160, 26.25%); 153 patients (95.6%) had at least one of these risk factors, 58 patients (36.32%) had two, and 14 (8.8%) had all three. Of the 42 hypertensive patients, 20 were on diuretic therapy. Seventeen patients (10.62%) had a family history of gout. There was no evidence that AS or AC hemoglobinopathy (32 and 13 cases, respectively) influenced the course or natural history of gout.
Conclusion: Although population-based studies are needed for confirmation, our study suggests that risk factors for gout in Togolese patients are similar to those in other parts of Africa and in Western countries.
Similar articles
-
[Gout in Togolese patients].Rev Rhum Mal Osteoartic. 1992 Jul-Sep;59(7-8):473-7. Rev Rhum Mal Osteoartic. 1992. PMID: 1485137 French.
-
[Semiological profile of gout in patients with AA, AS and AC hemoglobins].Tunis Med. 2010 Jan;88(1):30-2. Tunis Med. 2010. PMID: 20415210 French.
-
Gout in patients attending the rheumatology unit of Lomé Hospital.Br J Rheumatol. 1995 Sep;34(9):843-6. doi: 10.1093/rheumatology/34.9.843. Br J Rheumatol. 1995. PMID: 7582724
-
Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies.Arthritis Res Ther. 2018 Jul 5;20(1):136. doi: 10.1186/s13075-018-1612-1. Arthritis Res Ther. 2018. PMID: 29976236 Free PMC article.
-
Hypertension, its treatment, hyperuricaemia and gout.Curr Opin Rheumatol. 2013 Mar;25(2):217-22. doi: 10.1097/BOR.0b013e32835cedd4. Curr Opin Rheumatol. 2013. PMID: 23370375 Review.
Cited by
-
Risk factors for gout and prevention: a systematic review of the literature.Curr Opin Rheumatol. 2011 Mar;23(2):192-202. doi: 10.1097/BOR.0b013e3283438e13. Curr Opin Rheumatol. 2011. PMID: 21285714 Free PMC article.
-
Global epidemiology of gout: prevalence, incidence and risk factors.Nat Rev Rheumatol. 2015 Nov;11(11):649-62. doi: 10.1038/nrrheum.2015.91. Epub 2015 Jul 7. Nat Rev Rheumatol. 2015. PMID: 26150127 Review.
-
Rheumatic diseases in Africa.Nat Rev Rheumatol. 2021 Jun;17(6):363-374. doi: 10.1038/s41584-021-00603-4. Epub 2021 Apr 13. Nat Rev Rheumatol. 2021. PMID: 33850309 Free PMC article. Review.
-
Frequency and associations of chronic kidney disease among gout patients from a University Teaching Hospital in Nigeria.Reumatologia. 2018;56(1):17-23. doi: 10.5114/reum.2018.74744. Epub 2018 Feb 28. Reumatologia. 2018. PMID: 29686438 Free PMC article.
MeSH terms
LinkOut - more resources
Medical
Research Materials